SCHEMBL19686002

SCHEMBL19686002

Cn1c(Nc2cccc(Cl)c2)nc2cnc(NC3(C)CCOCC3)nc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.49
EGFR P00533 7/20 0.46
CYP1A2 P05177 3/20 0.40
HPGD P15428 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
POLB P06746 1/20 0.40
HSP90AA1 P07900 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAPT P10636 1/20 0.40
CYP2C9 P11712 1/20 0.40
MAPK1 P28482 1/20 0.40
CYP2C19 P33261 1/20 0.40
KMT2A Q03164 1/20 0.40
HSD17B10 Q99714 1/20 0.40
USP2 O75604 3/20 0.40
LMNA P02545 2/20 0.40
KDR P35968 2/20 0.40
ALDH1A1 P00352 2/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19665478 0.86 LMNA (0.40) GAAEGFRCYP1A2HPGDKDM4E
SCHEMBL29802600 0.86 LMNA (0.40) GAAEGFRCYP1A2HPGDKDM4E
SCHEMBL21385811 0.86 EGFR (0.53) EGFRCYP1A2CYP3A4CYP2C9USP2
SCHEMBL19685580 0.86 MAPK9 (0.50) EGFRCYP1A2MEN1KMT2AUSP2
SCHEMBL29802291 0.85 LMNA (0.39) GAAEGFRCYP1A2HPGDKDM4E
SCHEMBL19665766 0.85 LMNA (0.39) GAAEGFRCYP1A2HPGDKDM4E
SCHEMBL19666502 0.85 FLT3 (0.41) GAAEGFRCYP1A2MEN1CYP3A4
SCHEMBL29717615 0.85 FLT3 (0.41) GAAEGFRCYP1A2MEN1CYP3A4
SCHEMBL29717531 0.85 EGFR (0.41) GAAEGFRCYP1A2MEN1KMT2A
SCHEMBL19666426 0.85 EGFR (0.41) GAAEGFRCYP1A2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017210408-A1 ANIMAL AND HUMAN ANTI-TRYPANOSOMONAL AND ANTI-LEISHMANIA AGENTS CELGENE CORPORATION (US) 2017-12-07 WO disclosed